Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease tuberous sclerosis
Symptom C0037763|spasms
Sentences 10
PubMedID- 23796861 Epileptic spasms in tuberous sclerosis complex.
PubMedID- 23399947 Vigabatrin (vgb) has been shown to be particularly effective in the treatment of infantile spasms for those with tuberous sclerosis complex (tsc).
PubMedID- 21077355 Vigabatrin (vgb) is one of the most effective anti-epileptic drugs for tonic spasms, those accompanied with tuberous sclerosis complex (tsc), but is not available in japan.
PubMedID- 21127692 Chiron et al reported on a prospective trial comparing vigabatrin with hydrocortisone as initial treatment for infantile spasms attributable to tuberous sclerosis.
PubMedID- 23400943 Some efficacy trends were identified, including frequent successes with valproic acid with clonazepam for epilepsy with angelman syndrome; valproic acid, stiripentol, and clobazam (triple combination therapy) for epilepsy with dravet syndrome; and vigabatrin for infantile spasms associated with tuberous sclerosis complex.
PubMedID- 24382900 Vigabatrin is the drug of choice for infantile spasms associated with tuberous sclerosis.
PubMedID- 24910743 This result is in agreement with hancock et al, who reported that vigabatrin ceased infantile spasms in 54% of infants without tuberous sclerosis compared with 95% of infants with tuberous sclerosis.
PubMedID- 24808722 Vigabatrin often has marked efficacy in focal epilepsy or infantile spasms associated with tuberous sclerosis complex.
PubMedID- 25143766 Vigabatrin has been used in the treatment of is in europe since 1990, and seems highly effective in spasms due to tuberous sclerosis.
PubMedID- 22180964 Efficacy of topiramate for relapsed epileptic spasms with tuberous sclerosis: report of three cases.

Page: 1